Riduzione volumetrica dei turbinati inferiori con radiofrequenze: risultati clinici a lungo termine

Corso, Eugenio De; Bastanza, Giovanni; DonfranCEsCo, V. Di; Guidi, Maria Lavinia; Sbarra, Gloria Morelli; Passàli, Gc; Poscia, Andrea; Waure, Chiara de; Paludetti, Gaetano; Galli, Jacopo

doi:10.14639/0392-100x-964

Cited by 30 publications

(17 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Table 3.1 shows that the majority of Group A had an MLK score of 3 at baseline (T0), 17 The temporal trend of MLK's analysis in both groups is represented in Figures 3.1 and 3.2: Groups A and B showed a significative improvement between T0 and T1. Both groups showed no significative differences between T2 and T3 and between T3 and T4.…”

Section: Resultsmentioning

confidence: 97%

“…18 De Corso et al demonstrated that RFA provides an improvement in nasal airflow with a reduction in nasal obstructive symptoms in the short term, but its efficacy tends to decrease within 3 years. 17 Incandela et al suggested that urban residence and AR were significantly associated with lower long-term improvement after RFA. 19 Bipolar microdebrider technique for ITH might have several potential advantages.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Role of Quantic Molecular Resonance (QMR) in the Treatment of Inferior Turbinate Hypertrophy (ITH): Our Experience With Long-Term Follow-Up in Allergic and Nonallergic Rhinitis Refractory to Medical Therapy. Preliminary Results

et al. 2021

View full text Add to dashboard Cite

Objective: The aim of this study was to assess the long-term effectiveness of quantic molecular resonance (QMR) in the treatment of inferior turbinate hypertrophy (ITH) in allergic and nonallergic rhinitis refractory to medical therapy. Methods: This study enrolled 281 patients, 160 males (56.9%) and 121 females (43.1%), mean age 37.8 ± 4.1 years, range 18 to 71. Fifty-four patients have been lost to follow up and have been therefore excluded from the final analysis. Based on skin prick test results, 69 patients were considered allergic (group A) and 158 nonallergic (group B). All subjects underwent before surgery (T0) and 3 (T1), 12 (T2), 24 (T3), and 36 months (T4) after QMR treatment to: 4-phase rhinomanometric examination, nasal endoscopy evaluation, and visual analogue scale to quantify the subjective feelings about nasal obstruction. Results: Subjective and objective parameters showed statistically significant improvement in both groups. Group B parameters not changed during follow-up, while group A showed significant worsening between T1 and subsequent assessments. T4 outcome indicates a better result in nonallergic patients. Conclusions: In accordance with the literature, our preliminary data validate QMR treatment as a successful therapeutic option for nasal obstruction due to ITH. Nonallergic patients had a very good T4 outcome. Allergic patients showed a worsening trend after 1 year probably due to other causes.

show abstract

Section: Resultsmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 99%

The Role of Quantic Molecular Resonance (QMR) in the Treatment of Inferior Turbinate Hypertrophy (ITH): Our Experience With Long-Term Follow-Up in Allergic and Nonallergic Rhinitis Refractory to Medical Therapy. Preliminary Results

et al. 2021

View full text Add to dashboard Cite

show abstract

“…There may be concerns about recurrence of inferior turbinate hypertrophy after RFA. Though a lot of studies have shown sustainable results 2, 15 3, 8,13 and even 5 years 14,16 after RFA.…”

Section: Discussionmentioning

confidence: 99%

“…11,12 Long-term efficacy of RFA is demonstrated in several small retrospective studies. 8,[13][14][15][16] Clinical successful results persist 2, 15 3, 8,13 and even 5 years 14,16 after RFA.…”

Section: Introductionmentioning

confidence: 98%

Radiofrequency Ablation for Inferior Turbinate Hypertrophy: Predictive Factors for Short and Long-Term Outcomes

Sleurs

Postelmans

Smit

2022

Ann Otol Rhinol Laryngol

View full text Add to dashboard Cite

Objectives: Radiofrequency Ablation (RFA) is a widely used technique for treatment of nasal obstruction due to inferior turbinate hypertrophy. This study aims to evaluate short and long-term outcome after RFA. Secondly, predictive factors for this outcome were evaluated. Methods: A prospective clinical study was performed in 65 patients to evaluate short-term outcome and predictive factors (Study A). To evaluate long-term outcome and predictive factors we performed a second clinical study in 124 patients (Study B). Patients scored nasal symptoms on a 1 to 5 points visual analogue scale (VAS) and filled in questionnaires about their comorbidity, previous nasal surgery, and medication use. Results: Study A: There was significant short-term (6-8 weeks after RFA) improvement in nasal obstruction (VAS −1.3, P < .001), trouble exercising (VAS −1.5, P < .001), trouble sleeping (VAS −0.9, P < .001), snoring (VAS −1.1, P< .001), and hyposmia (VAS −0.6, P = .004). Smoking ( R2 = .065, P = .047) was a predictor for less optimized and previous use of decongestive nasal spray ( R2 = .135, P = .005) for better short-term outcome. Study B: Nasal obstruction significantly decreased in the long term (1-5 years after RFA) compared to VAS before RFA (VAS −1.5, P < .001), but slightly increased compared to VAS 6 to 8 weeks after RFA (VAS +0.3, P = .036). Allergy ( R2 = .066, P = .006), asthma ( R2 = .068, P = .005), and previous use of corticosteroid nasal spray ( R2 = .050, P = .016) were associated with a less optimized and older age ( R2 = .217, P < .001) with better long-term outcome. Conclusion: RFA is an efficient treatment for nasal obstruction, and improves sleeping, exercising, snoring, and hyposmia. Predictors for good short-term outcome were previous use of decongestive nasal spray and no smoking. Predictors for a less optimized long-term outcome were allergy, asthma, and previous use of corticosteroid nasal spray. Older age was associated with better long-term outcome.

show abstract

“…Bony outfracture, the most atraumatic and conservative IT surgery, 2301 can reduce the distance between IT and lateral nasal wall and enlarge the dimensions of the nasal airway when performed alone 2302,2303 or in conjunction with other techniques 2304,2305 . IT surgery via energy‐related techniques 2304–2363 and via direct tissue removal 1093,2296,2299,2303,2307,2310,2331,2332,2335,2336,2338,2344,2364–2376 have both been extensively studied, with reported high efficacy in reducing symptoms and increasing nasal volume and airflow with minimal complications. Of note, botulinum toxin injection 2377–2379 and high‐intensity focused ultrasound may also provide symptomatic relief, 2380,2381 though there remains limited evidence for their utility.…”

Section: Managementmentioning

confidence: 99%

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Wise

Damask

Roland

et al. 2023

Int Forum Allergy Rhinol

151

View full text Add to dashboard Cite

Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.

show abstract

Riduzione volumetrica dei turbinati inferiori con radiofrequenze: risultati clinici a lungo termine

Cited by 30 publications

References 33 publications

The Role of Quantic Molecular Resonance (QMR) in the Treatment of Inferior Turbinate Hypertrophy (ITH): Our Experience With Long-Term Follow-Up in Allergic and Nonallergic Rhinitis Refractory to Medical Therapy. Preliminary Results

The Role of Quantic Molecular Resonance (QMR) in the Treatment of Inferior Turbinate Hypertrophy (ITH): Our Experience With Long-Term Follow-Up in Allergic and Nonallergic Rhinitis Refractory to Medical Therapy. Preliminary Results

Radiofrequency Ablation for Inferior Turbinate Hypertrophy: Predictive Factors for Short and Long-Term Outcomes

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Contact Info

Product

Resources

About